22
Participants
Start Date
March 31, 2011
Primary Completion Date
November 30, 2011
Study Completion Date
November 30, 2011
fostamatinib
Oral tablets, repeated doses for 21 days (2 x 50mg BID)
Microgynon® 30 (Oral contraceptive)
Oral tablets, repeated doses
Placebo
Oral tablets BID, repeated doses for 21 days
Research Site, London
Lead Sponsor
AstraZeneca
INDUSTRY